Transforming RNA science into healthy expression.

We are a leading RNA therapeutics company working to empower endogenous protein production and improve health from within.

Learn More

Translate Bio

We are pioneering the translation of RNA therapeutics into transformative medicines.

Recent News

05.23 2018
Translate Bio Names John R. Schroer, CFA, Chief Financial Officer
04.12 2018
Translate Bio Announces FDA Clearance to Proceed with Phase 1/2 Clinical Trial in Patients with Cystic Fibrosis (CF)
11.06 2017
Translate Bio Appoints Ann Barbier, M.D., Ph.D., as Chief Medical Officer
10.03 2017
Translate Bio Names Daniella Beckman to Board of Directors

View All

@TranslateBio